fluorobenzenes has been researched along with Hyperactivity, Motor in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (33.33) | 18.2507 |
| 2000's | 2 (22.22) | 29.6817 |
| 2010's | 4 (44.44) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jiang, XL; Shen, HW; Yu, AM | 1 |
| Bonhaus, DW; McFarland, K; Price, DL | 1 |
| Anastasio, NC; Bubar, MJ; Cunningham, KA; Fox, RG; Gilbertson, SR; Moeller, FG; Rice, KC; Rosenzweig-Lipson, S; Stutz, SJ; Swinford, SE; Watson, CS | 1 |
| Geyer, MA; Halberstadt, AL; Powell, SB | 1 |
| Conway, MW; Heron-Maxwell, C; Monn, JA; O'Neill, MF; Ornstein, P | 1 |
| Bubar, MJ; Cunningham, KA; Filip, M | 1 |
| Eger, EI; Fang, Z; Halsey, MJ; Ionescu, P; Kandel, L; Koblin, DD; Laster, MJ; Sonner, J | 1 |
| Carlsson, A; Carlsson, ML; Martin, P; Waters, N; Waters, S | 1 |
| Carlsson, A; Carlsson, ML; Martin, P; Nilsson, M; Sorensen, SM; Waters, N; Waters, S | 1 |
9 other study(ies) available for fluorobenzenes and Hyperactivity, Motor
| Article | Year |
|---|---|
Modification of 5-methoxy-N,N-dimethyltryptamine-induced hyperactivity by monoamine oxidase A inhibitor harmaline in mice and the underlying serotonergic mechanisms.
Topics: Animals; Dose-Response Relationship, Drug; Drug Synergism; Fluorobenzenes; Harmaline; Hyperkinesis; Hypokinesia; Male; Methoxydimethyltryptamines; Mice; Monoamine Oxidase Inhibitors; Motor Activity; Piperazines; Piperidines; Pyridines; Serotonin 5-HT1 Receptor Agonists; Serotonin 5-HT2 Receptor Agonists | 2016 |
Pimavanserin, a 5-HT2A inverse agonist, reverses psychosis-like behaviors in a rodent model of Parkinson's disease.
Topics: Amphetamine; Amphetamines; Animals; Antipsychotic Agents; Behavior, Animal; Central Nervous System Stimulants; Disease Models, Animal; Dyskinesias; Fenfluramine; Fluorobenzenes; Hyperkinesis; Male; Motor Activity; Oxidopamine; Parkinson Disease; Piperidines; Psychotic Disorders; Rats, Sprague-Dawley; Receptor, Serotonin, 5-HT2A; Sensory Gating; Serotonin 5-HT2 Receptor Antagonists; Serotonin Agents; Serotonin Receptor Agonists; Substantia Nigra; Tyrosine 3-Monooxygenase; Urea | 2011 |
Synergism between a serotonin 5-HT2A receptor (5-HT2AR) antagonist and 5-HT2CR agonist suggests new pharmacotherapeutics for cocaine addiction.
Topics: Animals; Azepines; Cocaine-Related Disorders; Cues; Dose-Response Relationship, Drug; Drug Combinations; Drug Synergism; Fluorobenzenes; Humans; Hyperkinesis; Impulsive Behavior; Indoles; Male; Motor Activity; Piperidines; Rats; Rats, Sprague-Dawley; Reaction Time; Reinforcement Schedule; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Role of the 5-HT₂A receptor in the locomotor hyperactivity produced by phenylalkylamine hallucinogens in mice.
Topics: Aniline Compounds; Animals; Dose-Response Relationship, Drug; Drug Interactions; Fluorobenzenes; Hallucinogens; Hyperkinesis; Male; Mice; Mice, Knockout; Piperidines; Receptor, Serotonin, 5-HT2A; Serotonin 5-HT2 Receptor Agonists; Serotonin 5-HT2 Receptor Antagonists | 2013 |
Group II metabotropic glutamate receptor antagonists LY341495 and LY366457 increase locomotor activity in mice.
Topics: Amino Acids; Animals; Benzazepines; Dizocilpine Maleate; Dopamine Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Female; Fluorobenzenes; Haloperidol; Hyperkinesis; Mice; Motor Activity; Piperidines; Receptors, Metabotropic Glutamate; Serotonin Antagonists; Time Factors; Xanthenes | 2003 |
Contribution of serotonin (5-hydroxytryptamine; 5-HT) 5-HT2 receptor subtypes to the hyperlocomotor effects of cocaine: acute and chronic pharmacological analyses.
Topics: Amphetamines; Animals; Cocaine; Drug Interactions; Fluorobenzenes; Hyperkinesis; Indoles; Male; Phenols; Pyrazines; Rats; Rats, Wistar; Receptor, Serotonin, 5-HT2A; Receptor, Serotonin, 5-HT2B; Receptor, Serotonin, 5-HT2C; Serotonin Antagonists; Serotonin Receptor Agonists; Thiophenes | 2004 |
Anesthetic and convulsant properties of aromatic compounds and cycloalkanes: implications for mechanisms of narcosis.
Topics: Anesthesia, Inhalation; Anesthetics, Inhalation; Animals; Benzene; Benzene Derivatives; Convulsants; Cycloheptanes; Cyclohexanes; Cycloparaffins; Cyclopentanes; Desflurane; Fluorobenzenes; Fluorocarbons; Hyperkinesis; Isoflurane; Lipids; Male; Molecular Conformation; Molecular Structure; Muscle Contraction; Rats; Rats, Sprague-Dawley; Solubility; Structure-Activity Relationship; Toluene; Xylenes | 1996 |
MK-801-induced hyperlocomotion: differential effects of M100907, SDZ PSD 958 and raclopride.
Topics: Animals; Dizocilpine Maleate; Dopamine Antagonists; Dopamine D2 Receptor Antagonists; Dose-Response Relationship, Drug; Drug Interactions; Excitatory Amino Acid Antagonists; Fluorobenzenes; Hyperkinesis; Male; Mice; Motor Activity; Piperidines; Quinoxalines; Raclopride; Receptor, Serotonin, 5-HT2A; Receptors, Dopamine D1; Receptors, Serotonin; Salicylamides; Serotonin Antagonists | 1997 |
The 5-HT2A receptor antagonist M100907 is more effective in counteracting NMDA antagonist- than dopamine agonist-induced hyperactivity in mice.
Topics: Amphetamine; Animals; Dizocilpine Maleate; Dopamine; Dopamine Agonists; Dopamine Uptake Inhibitors; Dose-Response Relationship, Drug; Excitatory Amino Acid Antagonists; Fluorobenzenes; Glutamic Acid; Haloperidol; Hyperkinesis; Male; Mice; Mice, Inbred Strains; Motor Activity; N-Methylaspartate; Piperazines; Piperidines; Receptor, Serotonin, 5-HT2A; Receptors, Serotonin; Serotonin Antagonists | 1999 |